Published in Toxicon on October 08, 2009
Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol (2014) 1.51
Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus. Mol Ther (2012) 0.94
Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications. World J Gastroenterol (2014) 0.88
Gene expression profiling in gastric mucosa from Helicobacter pylori-infected and uninfected patients undergoing chronic superficial gastritis. PLoS One (2012) 0.80
An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors. Mol Ther (2013) 0.80
Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer. Iran Biomed J (2016) 0.77
High yield purification of Helicobacter pylori neutrophil-activating protein overexpressed in Escherichia coli. BMC Biotechnol (2015) 0.77
Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid. PLoS One (2013) 0.77
Structures and metal-binding properties of Helicobacter pylori neutrophil-activating protein with a di-nuclear ferroxidase center. Biomolecules (2014) 0.77
Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes. J Inflamm Res (2015) 0.76
The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells. Sci Rep (2017) 0.75
Chinese Helicobacter pylori vaccine: Solution for an old challenge? World J Gastrointest Pharmacol Ther (2016) 0.75
IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect (2004) 1.82
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol (2002) 1.61
T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci U S A (2003) 1.37
Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity. J Exp Med (2003) 1.14
Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein. J Allergy Clin Immunol (2008) 1.08
Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol (2005) 1.05
The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. PLoS Pathog (2009) 1.00
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A (2012) 0.99
Novel immunotherapeutic strategies of gastric cancer treatment. J Biomed Biotechnol (2011) 0.99
Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis. Infect Immun (2008) 0.97
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood (2011) 0.94
Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis. PLoS One (2012) 0.94
The Bordetella pertussis adenylate cyclase toxin binds to T cells via LFA-1 and induces its disengagement from the immune synapse. J Exp Med (2011) 0.92
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A. Arthritis Rheum (2013) 0.92
The effect of Helicobacter pylori on asthma and allergy. J Asthma Allergy (2010) 0.90
Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma. J Biomed Biotechnol (2010) 0.90
The story so far: Helicobacter pylori and gastric autoimmunity. Int Rev Immunol (2005) 0.88
The adenylate cyclase toxin of Bacillus anthracis is a potent promoter of T(H)17 cell development. J Allergy Clin Immunol (2011) 0.86
T cells in gastric cancer: friends or foes. Clin Dev Immunol (2012) 0.83
Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. Blood (2005) 0.83
To treat or not to treat Helicobacter pylori to benefit asthma patients. Expert Rev Respir Med (2010) 0.81
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. Clin Dev Immunol (2011) 0.80
Impaired TH2 response in patients with Vav1-deficient common variable immunodeficiency with T-cell defects. J Allergy Clin Immunol (2010) 0.79
Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils. Cell Microbiol (2010) 0.78
Management of Helicobacter pylori infection. Expert Rev Anti Infect Ther (2010) 0.78
Characterization of H+,K+-ATPase T cell epitopes in human autoimmune gastritis. Eur J Immunol (2003) 0.77
Reply to letter by Nardelli and Schell commenting on the pathogenesis of Lyme arthritis. Arthritis Rheum (2009) 0.75
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. J Leukoc Biol (2013) 0.75
[Oral vitamin B12: Efficacy and safety data in 31 patients with pernicious anemia and food-cobalamin malabsorption]. Presse Med (2010) 0.75